Pharmaceutical Products Companies By Ebitda
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
EBITDA
| EBITDA | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | CEROW | CERo Therapeutics Holdings | 0.11 | 28.30 | 3.25 | ||
| 2 | VTRS | Viatris | 0.00 | 1.69 | 0.00 | ||
| 3 | VRTX | Vertex Pharmaceuticals | (0.15) | 1.12 | (0.17) | ||
| 4 | ELAN | Elanco Animal Health | (0.10) | 1.99 | (0.19) | ||
| 5 | NWBO | Northwest Biotherapeutics | (0.04) | 3.96 | (0.16) | ||
| 6 | VYGR | Voyager Therapeutics | 0.03 | 4.29 | 0.13 | ||
| 7 | EGRX | Eagle Pharmaceuticals | (0.06) | 5.24 | (0.29) | ||
| 8 | DVAX | Dynavax Technologies | (0.15) | 1.54 | (0.22) | ||
| 9 | XOMAP | XOMA Corp | 0.03 | 0.56 | 0.02 | ||
| 10 | XOMAO | XOMA Corporation | 0.06 | 0.54 | 0.03 | ||
| 11 | HROWL | Harrow Health 8625 | 0.14 | 0.50 | 0.07 | ||
| 12 | VCEL | Vericel Corp Ord | 0.04 | 2.12 | 0.09 | ||
| 13 | SER | Serina Therapeutics | (0.10) | 9.00 | (0.90) | ||
| 14 | ELAB | Elevai Labs | 0.04 | 5.61 | 0.20 | ||
| 15 | VIRI | Virios Therapeutics Llc | 0.06 | 8.30 | 0.53 | ||
| 16 | CDTTW | Conduit Pharmaceuticals | 0.19 | 41.83 | 8.13 | ||
| 17 | VRAX | Virax Biolabs Group | (0.04) | 3.92 | (0.18) | ||
| 18 | CDIOW | Cardio Diagnostics Holdings | (0.02) | 17.73 | (0.34) | ||
| 19 | DRUG | Bright Minds Biosciences | (0.23) | 4.27 | (0.97) | ||
| 20 | SKYE | Skye Bioscience, Common | 0.22 | 14.55 | 3.16 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital. In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.